The goal of the survey is to gather comprehensive information about the availability of diagnostic, prognostic, and therapeutic options for patients with Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) across different countries.
The survey also aims to raise global awareness about disparities in access to care and to help inform future initiatives aimed at improving equity. The collected data will be used to create presentations and peer-reviewed publications.
A comprehensive list of representatives from different countries has been developed and individuals will receive the survey in November 2025.Participants are encouraged to provide responses to the survey that reflect the general practices and resources available in their own country, rather than just those of their personal institution or clinical practice.